ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.130,43
1,31%
Dow Jones
38.677,46
1,18%
Euro vs US Dollar
1,07685
0,36%
Bitcoin
61.678,09
4,32%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) News

WGS GeneDx Holdings Corporation

20,00
0,50 (2,56%)
Zuletzt aktualisiert: 21:10:48
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
GeneDx Holdings Corporation WGS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,50 2,56% 20,00 21:10:48
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
19,47 19,09 21,71 19,50
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202422:05GLOBEGeneDx Reports First Quarter 2024 Financial Results and..
23.4.202414:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
04.4.202422:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
14.3.202413:30GLOBEGeneDx to Present Data at the 2024 American College of..
05.3.202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
23.2.202422:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20.2.202422:28EDGAR2Form 8-K - Current report
20.2.202422:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
01.2.202422:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
24.1.202422:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
23.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202414:58EDGAR2Form 8-K - Current report
08.1.202414:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
04.1.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202303:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202314:30GLOBEGeneDx Presents New Data at the American Epilepsy Society..
28.11.202322:05GLOBEGeneDx to Participate in 6th Annual Evercore ISI HealthCONx..
20.11.202322:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
17.11.202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
03.11.202321:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30.10.202321:33EDGAR2Form 8-K - Current report
30.10.202321:05GLOBEGeneDx Reports Third Quarter 2023 Financial Results and..
23.10.202323:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.10.202322:05GLOBEGeneDx to Report Third Quarter 2023 Financial Results on..
03.10.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.9.202322:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
20.9.202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.9.202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202300:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202300:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.9.202314:00GLOBEGeneDx Announces Evolution of Executive Leadership Team
06.9.202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202314:00GLOBEGeneDx Announces Industry-Leading Accomplishment of 500,000..
21.8.202313:00GLOBEGeneDx Announces Data Demonstrating that Whole Exome and..
09.8.202302:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
08.8.202322:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
08.8.202322:13EDGAR2Form 8-K - Current report
08.8.202322:05GLOBEGeneDx Reports Second Quarter 2023 Financial Results and..
07.8.202314:00GLOBEPacBio and GeneDx Launch Research Collaboration with the..
27.7.202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.7.202323:04EDGAR2Form 8-K - Current report
22.7.202303:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.7.202313:05GLOBEGeneDx and Prognos Health Announce Strategic Partnership to..

Kürzlich von Ihnen besucht

NASDAQ
WGS
GeneDx
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten